Medicament classification for vitamin combinations upheld where therapeutic use and full disclosure defeated extended limitation.

Fixed-dose combinations of Vitamins B1, B6 and B12, marketed in measured doses and packed for retail sale, were held to answer the description of medicaments under Chapter 30 rather than intermixtures of vitamins under Chapter 29, because the contemporaneous medical and regulatory material supported therapeutic use. The extended limitation period was also held inapplicable because the assessee had filed classification declarations with full disclosure, and the department was aware of the declared classification; suppression or deliberate misdeclaration was not established. The demand and penalties were therefore not sustainable.

---

---

Issues: (i) Whether fixed dose combinations of Vitamins B1, B6 and B12 were correctly classifiable as medicaments under Chapter 30 of the Central Excise Tariff Act, 1985 or as intermixtures of vitamins under Chapter sub-heading 29.36; (ii) Whether the extended period of limitation was invocable on the ground of suppression or misdeclaration.

Issue (i): Whether fixed dose combinations of Vitamins B1, B6 and B12 were correctly classifiable as medicaments under Chapter 30 of the Central Excise Tariff Act, 1985 or as intermixtures of vitamins under Chapter sub-heading 29.36.

Analysis: The product was marketed in measured doses and packed for retail sale. The record showed that the drugs authorities had earlier indicated therapeutic usefulness in specified conditions, and the manufacturers had been following that position in their product literature. The reasoning adopted in the impugned order gave overriding weight to the later notification under the Drugs and Cosmetics Act, 1940, without adequately dealing with the earlier technical view supporting therapeutic use. On the material placed, the product answered the description of a medicament rather than a mere vitamin mixture.

Conclusion: The goods were correctly classifiable under Chapter 30, in favour of the assessee.

Issue (ii): Whether the extended period of limitation was invocable on the ground of suppression or misdeclaration.

Analysis: The assessee had been filing classification declarations with full disclosure of the nature of the goods. The department was aware of the declared classification and the dispute arose only after the later governmental notification. In these circumstances, the ingredients for suppression or deliberate misdeclaration were not made out, and the longer limitation period could not be applied.

Conclusion: The extended period of limitation was not invocable, in favour of the assessee.

Final Conclusion: The demand and penalties could not be sustained, and the assessee succeeded while the revenue challenge failed.

Ratio Decidendi: A product packed and sold in measured doses may be classified as a medicament when the contemporaneous medical and regulatory record supports therapeutic use, and the extended limitation period cannot be invoked absent clear suppression or misdeclaration where full classification disclosure was made.

---